ClinicalTrials.Veeva

Menu

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

AstraZeneca logo

AstraZeneca

Status and phase

Completed
Phase 3

Conditions

Hypercholesterolemia

Treatments

Procedure: aortic pulse wave velocity measurements
Drug: Rosuvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00240279
4522IL/0096 Dutch SubStudy
D3562C00096

Details and patient eligibility

About

To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Signed informed consent, between 50 and 80 years of age, end stage renal failure patients receiving hemodialysis

Exclusion criteria

  • Received statins within past 6 months, a clear indication for use of lipid altering drug, contra indication for lipid altering drug, history of statin induced myopathy items in very

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems